Coexisting NRAS and BRAF Mutations in Primary Familial Melanomas with Specific CDKN2A Germline Alterations
Open Access
- 1 February 2010
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 130 (2), 618-620
- https://doi.org/10.1038/jid.2009.287
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Lack of Cytoplasmic ERK Activation Is an Independent Adverse Prognostic Factor in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2008
- Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body siteMolecular Oncology, 2007
- Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant MelanomaCancer Epidemiology, Biomarkers & Prevention, 2007
- NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencingMelanoma Research, 2006
- Examination of Mutations in BRAF, NRAS, and PTEN in Primary Cutaneous MelanomaJournal of Investigative Dermatology, 2006
- Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosisJournal of Carcinogenesis, 2004
- Frequency of UV-Inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A MutationsJNCI Journal of the National Cancer Institute, 2003
- High frequency of BRAF mutations in neviNature Genetics, 2002
- Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.2002
- Mutations of the BRAF gene in human cancerNature, 2002